Global Hemostats Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Hemostats Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
According to APO Research, The global Hemostats market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Hemostats is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Hemostats include Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation and B Braun Melsungen AG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats.
The Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Hemostats segment by Type

Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Hemostats segment by Application

Prehospital Treatment
Hospital Treatment
Hemostats Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hemostats Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Hemostats Sales Estimates and Forecasts (2019-2030)
1.3 Hemostats Market by Type
1.3.1 Thrombin-Based Hemostats
1.3.2 Oxidized Regenerated Cellulose Based Hemostats
1.3.3 Combination Hemostats
1.3.4 Gelatin Based Hemostats
1.3.5 Collagen Based Hemostats
1.4 Global Hemostats Market Size by Type
1.4.1 Global Hemostats Market Size Overview by Type (2019-2030)
1.4.2 Global Hemostats Historic Market Size Review by Type (2019-2024)
1.4.3 Global Hemostats Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Hemostats Sales Breakdown by Type (2019-2024)
1.5.2 Europe Hemostats Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Hemostats Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Hemostats Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Hemostats Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Hemostats Industry Trends
2.2 Hemostats Industry Drivers
2.3 Hemostats Industry Opportunities and Challenges
2.4 Hemostats Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Hemostats Revenue (2019-2024)
3.2 Global Top Players by Hemostats Sales (2019-2024)
3.3 Global Top Players by Hemostats Price (2019-2024)
3.4 Global Hemostats Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Hemostats Key Company Manufacturing Sites & Headquarters
3.6 Global Hemostats Company, Product Type & Application
3.7 Global Hemostats Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Hemostats Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hemostats Players Market Share by Revenue in 2023
3.8.3 2023 Hemostats Tier 1, Tier 2, and Tier 3
4 Hemostats Regional Status and Outlook
4.1 Global Hemostats Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Hemostats Historic Market Size by Region
4.2.1 Global Hemostats Sales in Volume by Region (2019-2024)
4.2.2 Global Hemostats Sales in Value by Region (2019-2024)
4.2.3 Global Hemostats Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Hemostats Forecasted Market Size by Region
4.3.1 Global Hemostats Sales in Volume by Region (2025-2030)
4.3.2 Global Hemostats Sales in Value by Region (2025-2030)
4.3.3 Global Hemostats Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Hemostats by Application
5.1 Hemostats Market by Application
5.1.1 Prehospital Treatment
5.1.2 Hospital Treatment
5.2 Global Hemostats Market Size by Application
5.2.1 Global Hemostats Market Size Overview by Application (2019-2030)
5.2.2 Global Hemostats Historic Market Size Review by Application (2019-2024)
5.2.3 Global Hemostats Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Hemostats Sales Breakdown by Application (2019-2024)
5.3.2 Europe Hemostats Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Hemostats Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Hemostats Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Hemostats Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Ethicon
6.1.1 Ethicon Comapny Information
6.1.2 Ethicon Business Overview
6.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ethicon Hemostats Product Portfolio
6.1.5 Ethicon Recent Developments
6.2 Pfizer
6.2.1 Pfizer Comapny Information
6.2.2 Pfizer Business Overview
6.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Hemostats Product Portfolio
6.2.5 Pfizer Recent Developments
6.3 Baxter International Inc.
6.3.1 Baxter International Inc. Comapny Information
6.3.2 Baxter International Inc. Business Overview
6.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Baxter International Inc. Hemostats Product Portfolio
6.3.5 Baxter International Inc. Recent Developments
6.4 C. R. Bard
6.4.1 C. R. Bard Comapny Information
6.4.2 C. R. Bard Business Overview
6.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C. R. Bard Hemostats Product Portfolio
6.4.5 C. R. Bard Recent Developments
6.5 The Medicines Company
6.5.1 The Medicines Company Comapny Information
6.5.2 The Medicines Company Business Overview
6.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Medicines Company Hemostats Product Portfolio
6.5.5 The Medicines Company Recent Developments
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Comapny Information
6.6.2 Anika Therapeutics Business Overview
6.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anika Therapeutics Hemostats Product Portfolio
6.6.5 Anika Therapeutics Recent Developments
6.7 Advanced Medical Solutions
6.7.1 Advanced Medical Solutions Comapny Information
6.7.2 Advanced Medical Solutions Business Overview
6.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Advanced Medical Solutions Hemostats Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments
6.8 Integra LifeSciences Corporation
6.8.1 Integra LifeSciences Corporation Comapny Information
6.8.2 Integra LifeSciences Corporation Business Overview
6.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
6.8.5 Integra LifeSciences Corporation Recent Developments
6.9 B Braun Melsungen AG
6.9.1 B Braun Melsungen AG Comapny Information
6.9.2 B Braun Melsungen AG Business Overview
6.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B Braun Melsungen AG Hemostats Product Portfolio
6.9.5 B Braun Melsungen AG Recent Developments
6.10 Gelita Medical GmbH
6.10.1 Gelita Medical GmbH Comapny Information
6.10.2 Gelita Medical GmbH Business Overview
6.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gelita Medical GmbH Hemostats Product Portfolio
6.10.5 Gelita Medical GmbH Recent Developments
6.11 Equimedical
6.11.1 Equimedical Comapny Information
6.11.2 Equimedical Business Overview
6.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Equimedical Hemostats Product Portfolio
6.11.5 Equimedical Recent Developments
6.12 Vascular Solutions
6.12.1 Vascular Solutions Comapny Information
6.12.2 Vascular Solutions Business Overview
6.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vascular Solutions Hemostats Product Portfolio
6.12.5 Vascular Solutions Recent Developments
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Comapny Information
6.13.2 Marine Polymer Technologies Business Overview
6.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Marine Polymer Technologies Hemostats Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments
6.14 Z-Medica, LLC
6.14.1 Z-Medica, LLC Comapny Information
6.14.2 Z-Medica, LLC Business Overview
6.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Z-Medica, LLC Hemostats Product Portfolio
6.14.5 Z-Medica, LLC Recent Developments
6.15 CryoLife
6.15.1 CryoLife Comapny Information
6.15.2 CryoLife Business Overview
6.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CryoLife Hemostats Product Portfolio
6.15.5 CryoLife Recent Developments
6.16 BioCer Entwicklungs-GmbH.
6.16.1 BioCer Entwicklungs-GmbH. Comapny Information
6.16.2 BioCer Entwicklungs-GmbH. Business Overview
6.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
6.16.5 BioCer Entwicklungs-GmbH. Recent Developments
6.17 Biom'Up SAS
6.17.1 Biom'Up SAS Comapny Information
6.17.2 Biom'Up SAS Business Overview
6.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Biom'Up SAS Hemostats Product Portfolio
6.17.5 Biom'Up SAS Recent Developments
7 North America by Country
7.1 North America Hemostats Sales by Country
7.1.1 North America Hemostats Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Hemostats Sales by Country (2019-2024)
7.1.3 North America Hemostats Sales Forecast by Country (2025-2030)
7.2 North America Hemostats Market Size by Country
7.2.1 North America Hemostats Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Hemostats Market Size by Country (2019-2024)
7.2.3 North America Hemostats Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Hemostats Sales by Country
8.1.1 Europe Hemostats Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Hemostats Sales by Country (2019-2024)
8.1.3 Europe Hemostats Sales Forecast by Country (2025-2030)
8.2 Europe Hemostats Market Size by Country
8.2.1 Europe Hemostats Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Hemostats Market Size by Country (2019-2024)
8.2.3 Europe Hemostats Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Hemostats Sales by Country
9.1.1 Asia-Pacific Hemostats Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Hemostats Sales by Country (2019-2024)
9.1.3 Asia-Pacific Hemostats Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Hemostats Market Size by Country
9.2.1 Asia-Pacific Hemostats Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Hemostats Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Hemostats Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Hemostats Sales by Country
10.1.1 Latin America Hemostats Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Hemostats Sales by Country (2019-2024)
10.1.3 Latin America Hemostats Sales Forecast by Country (2025-2030)
10.2 Latin America Hemostats Market Size by Country
10.2.1 Latin America Hemostats Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Hemostats Market Size by Country (2019-2024)
10.2.3 Latin America Hemostats Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Hemostats Sales by Country
11.1.1 Middle East and Africa Hemostats Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Hemostats Sales by Country (2019-2024)
11.1.3 Middle East and Africa Hemostats Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Hemostats Market Size by Country
11.2.1 Middle East and Africa Hemostats Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Hemostats Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Hemostats Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Hemostats Value Chain Analysis
12.1.1 Hemostats Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hemostats Production Mode & Process
12.2 Hemostats Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hemostats Distributors
12.2.3 Hemostats Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings